- The European Commission today authorized Pfizer's (PFE +1.0%) COVID-19 antiviral pill Paxlovid.
- The move follows the recommendation of authorization from a panel of European Medicines Agency ("EMA") advisors.
- The Commission is still weighing authorization of Merck's (MRK -0.1%) COVID antiviral, molnupiravir. However, the EMA's advisory panel previously recommended approval.